Viral heart disease — treatment

2017 ◽  
pp. 1300-1306 ◽  
Author(s):  
Agnieszka Pawlak ◽  
Katarzyna E. Gil ◽  
Marcus Dörr
Keyword(s):  
Heart Disease ◽  
Disease Treatment ◽  
Viral Heart Disease

Viral heart disease: molecular diagnosis, clinical prognosis, and treatment strategies

2004 ◽  
Vol 193 (2-3) ◽  
pp. 65-69 ◽  
Author(s):  
Matthias Pauschinger ◽  
Kumaran Chandrasekharan ◽  
Michel Noutsias ◽  
Uwe K�hl ◽  
Lothar Peter Schwimmbeck ◽  
...  
Keyword(s):  
Heart Disease ◽  
Molecular Diagnosis ◽  
Treatment Strategies ◽  
Clinical Prognosis ◽  
Viral Heart Disease

A new approach to the comparative analysis of health systems: invasive treatment for heart disease in the US, France, and their two world cities

2007 ◽  
Vol 2 (1) ◽  
pp. 73-92 ◽  
Author(s):  
Michael K. Gusmano ◽  
Victor G. Rodwin ◽  
Daniel Weisz ◽  
Dhiman Das
Keyword(s):  
Heart Disease ◽  
Health Resources ◽  
Invasive Treatment ◽  
Disease Treatment ◽  
World Cities ◽  
New Approach ◽  
The Us ◽  
Developed Nations ◽  
Revascularization Procedures ◽  
Cross National

Cross-national comparisons that assess dimensions of health system performance indicate that the US provides higher rates of revascularization procedures than France and other developed nations, but we believe these findings are misleading. In this paper, we compare the use of these procedures in the US, France and their two world cities, Manhattan and Paris. In doing so, we address a number of limitations associated with existing cross-national comparisons of heart disease treatment. After adjusting for the prevalence of disease in these nations and cities, we found that residents of France aged 45–64 years receive more revascularization procedures than residents of the US and that Parisians receive more revascularizations than residents of Manhattan. Older residents 65 years and over (65+) in the US receive more of these procedures than their French counterparts, but the differences are not nearly as great as previous studies suggest. Moreover, our data on Manhattan and Paris where the population and level of health resources are more comparable, indicate that older Parisians obtain more revascularization procedures than older Manhattanites. Finally, we found that the use of revascularization procedures is significantly lower in Manhattan among persons without private health insurance and among racial and ethnic minorities.

Viral Heart Disease — A Precursor of Congestive Cardiomyopathy

1984 ◽  
pp. 95-98 ◽  
Author(s):  
C. L. Miklozek ◽  
P. C. Come ◽  
H. D. Royal ◽  
C. S. Crumpacker ◽  
W. H. Abelmann
Keyword(s):  
Heart Disease ◽  
Congestive Cardiomyopathy ◽  
Viral Heart Disease

The role of transgenic knockout models in defining the pathogenesis of viral heart disease

1995 ◽  
Vol 16 (suppl O) ◽  
pp. 25-27 ◽  
Author(s):  
P. Liu ◽  
J. Penninger ◽  
K. Aitken ◽  
M. Sole ◽  
T. Mak
Keyword(s):  
Heart Disease ◽  
Viral Heart Disease

Viral Heart Disease

2016 ◽  
pp. 99-113
Author(s):  
Bruce M. McManus ◽  
Michael Seidman ◽  
Karin Klingel ◽  
Honglin Luo
Keyword(s):  
Heart Disease ◽  
Viral Heart Disease
Sign in / Sign up

Export Citation Format

Share Document